Form 4: Intensity Therapeutics Director Acquires Stock Options
SEC Form 4
Mark A. Goldberg, a director of Intensity Therapeutics, Inc., acquired stock options for 50,000 shares on March 6, 2024.
Summary
- On March 6, 2024, Mark A. Goldberg, a director of Intensity Therapeutics, Inc., acquired stock options.
- The stock options grant the right to buy 50,000 shares of common stock at an exercise price of $5.19.
- The options vest in four equal annual installments starting on March 6, 2024, and expire on March 6, 2034.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of stock option grants to a company director.
Industry Context
This is a standard disclosure related to executive compensation and insider transactions, common in the biopharmaceutical industry.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of stock option transaction |
| 03/06/2024 | First vesting date of the stock options |
| 03/06/2034 | Expiration date of the stock options |
| 03/07/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.